PomBase home

Reference - PMID:26610878 - Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis.

Reference summary

PubMed ID
PMID:26610878
Title
Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis.
Authors
Gertz MA, Benson MD, Dyck PJ, Grogan M, Coelho T, Cruz M, Berk JL, Plante-Bordeneuve V, Schmidt HHJ, Merlini G
Citation
J Am Coll Cardiol 2015 Dec 01;66(21):2451-2466
Publication year
2015
Abstract
Transthyretin amyloidosis is a fatal disorder that is characterized primarily by progressive neuropathy and cardiomyopathy. It occurs in both a mutant form (with autosomal dominant inheritance) and a wild-type form (with predominant cardiac involvement). This article guides clinicians as to when the disease should be suspected, describes the appropriate diagnostic evaluation for those with known or suspected amyloidosis, and reviews the interventions currently available for affected patients.

Annotation

Disease association

MONDO:0007100 - familial amyloid neuropathy

Genes: